A first in human, phase I trial of NP137, a first-in-class antibody targeting netrin-1, in patients with advanced refractory solid tumors

Philippe A. Cassier, Lauriane Eberst, G. Garin, Yann Courbebaisse, C. Terret, M. Robert, Jean‐Sébastien Frenel, Stéphane Depil, Jean‐Pierre Delord, David Pérol,

Annals of Oncology · 2019 · 17 citations · 0 references

Concepts